XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $1.23M invested in XTL Biopharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$17K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$1K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$1.07M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.07M | 1,040,194 | -71,768 | -6% |
|
2
Invesco
Atlanta,
Georgia
| $134K | 129,811 | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $17K | 15,858 | +15,858 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1K | 800 | +700 | +700% |
|
|
5
UBS Group
Zurich,
Switzerland
| – | – | -363 | Closed |
|
6
Morgan Stanley
New York
| $0 | 8 | – | – |
|